Among enzymes activated by NrF2, heme oxygenase-1 (HO-1) is a promising therapeutic target for ischemia-reperfusion injury (IRI) due to its abundant antioxidant response elements (AREs) in its promoter region. This evidence concerns the gene HMOX1 and ischemia reperfusion injury.